COMPARE · Reviewed August 4, 2026
ADUS vs EHC
Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.7, EHC scored 70.4 — ADUS leads.
Compare another set
Different reporting periods. ADUS's fundamentals are as of June 2026, but EHC's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
ADUS
Addus HomeCare Corporation
74.7
$113.66 · $2.1B
fundamentals as of
Score gap
4.3
ADUS leads
EHC
Encompass Health Corporation
70.4
$110.50 · $11.0B
fundamentals as of
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
EHC
58
Qualityreturns · margins · balance sheet
69
92
Growthrevenue & earnings expansion
76
78
Valuevaluation vs sector peers
67
ADUS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
EHC
$155mC
FCF
$464mC
+15.9%B+
Rev
+10.0%B
0.12B+
D/E
0.83C+
21.0xB+
P/E
18.9xA-
1.12B+
PEG
0.41A
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
EHC
24% below
Price vs fair valuelower is cheaper
4% below
~-1%/yr
Growth the price implies10-yr FCF · lower = less priced in
~5%/yr
+25%
1-yr DCF upside
-4%
+32%
5-yr DCF upside
+4%
+43%
10-yr DCF upside
+17%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
EHC
Why this score
- Raising its dividend
The companies
ADUSAddus HomeCare Corporation
Why now
Medical Care Facilities · market cap $2.1b. 9% off the 52-week high of $124.44. Revenue growing +16%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $133.54 (implying +17% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
EHCEncompass Health Corporation
Why now
Medical Care Facilities · market cap $11.0b. 14% off the 52-week high of $127.99. Revenue growing +10%, comfortably above the S&P median. PEG 0.41 — paying under fair value for the growth rate. 12 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $140.50 (implying +27% upside).
Moat
ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.